Sandimmun 250 mg/5 ml concentrate for solution for infusion
Spain
Table of Contents
Package leaflet: Information for the user
Introduction
Package leaflet: Information for the patient
Sandimmun 250mg/5 ml concentrate for solution for infusion
ciclosporin
Read the entire leaflet carefully before you start using this medicine, because it contains important information for you.
-
Keep this leaflet, as you may need to read it again.
-
If you have any questions, consult your doctor or pharmacist.
-
This medicine has been prescribed for you only, and you should not give it to other people, even if they have the same symptoms as you, because it may harm them.
-
If you experience any adverse effects, consult your doctor or pharmacist, even if such effects are not listed in this leaflet. See section 4.
Leaflet contents:
- What Sandimmun is and what it is used for
- What you need to know before using Sandimmun
- How to use Sandimmun
- Possible adverse effects
- How to store Sandimmun
- Contents of the pack and other information
1. What Sandimmun is and what it is used for
What Sandimmun is
The name of your medicine is Sandimmun. It contains the active substance ciclosporin. The concentrate is used to prepare a solution that is administered by intravenous infusion. It belongs to a group of medicines known as immunosuppressants. These medicines are used to reduce the body's immune responses.
What Sandimmun is used for and how it works
Sandimmun is used to control your body's immune system after an organ transplant, including bone marrow and stem cell transplants. It prevents rejection of transplanted organs by suppressing the development of certain cells that would normally attack the transplanted tissue.
2. What you need to know before using Sandimmun
Sandimmun will only be prescribed by a physician experienced in transplantation.
Carefully follow all instructions provided by your doctor. These may differ from the general information contained in this leaflet.
Do not use Sandimmun:
-
If you are allergic to ciclosporin or to any of the other ingredients of this medicine (listed in section 6; also see section “Sandimmun contains castor oil and ethanol”).
-
with medications containing Hypericum perforatum (St. John's wort).
-
with medications containing dabigatran etexilate (used to prevent blood clots after surgery) or bosentan and aliskiren (used to lower high blood pressure).
If any of these apply to you, do not use Sandimmun and inform your doctor. If you are unsure, consult your doctor before using Sandimmun.
Warnings and precautions
Before and during treatment with Sandimmun, inform your doctor immediately:
- if you develop any signs of infection, such as fever or sore throat. Sandimmun suppresses the immune system and may also affect your body’s ability to fight infections.
- if you have liver problems.
- if you have kidney problems. Your doctor will perform regular blood tests and may adjust your dose if necessary.
- if you have high blood pressure. Your doctor will monitor your blood pressure regularly and may prescribe medication to lower it if needed.
- if you have low levels of magnesium in your body. Your doctor may administer magnesium supplements, especially shortly after transplantation.
- if you have high levels of potassium in your blood.
- if you suffer from gout.
- if you need to receive a vaccine.
If any of the above conditions occur before or during treatment with Sandimmun, inform your doctor immediately.
Sun protection and sunlight exposure
Sandimmun suppresses your immune system. This may increase the risk of developing cancer, particularly of the skin and lymphatic system. Therefore, you should limit your exposure to sunlight and UV radiation by:
- wearing appropriate protective clothing,
- frequently applying a sunscreen with a high protection factor.
Talk to your doctor before taking Sandimmun:
- if you have or have had alcohol-related problems,
- if you have epilepsy,
- if you have any liver problems,
- if you are pregnant,
- if you are breastfeeding,
- if this medicine is prescribed for a child.
If any of these situations apply to you (or you are unsure), inform your doctor before taking Sandimmun. This is because this medicine contains alcohol (see section “Sandimmun contains castor oil and ethanol” below).
Monitoring during treatment with Sandimmun
Your doctor will monitor:
- blood levels of ciclosporin, especially if you have undergone transplantation,
- your blood pressure before starting treatment and regularly during treatment,
- the function of your liver and kidneys,
- your blood lipid levels (fats).
If you have any questions about how Sandimmun works or why it has been prescribed for you, consult your doctor.
Children and adolescents
Experience with Sandimmun in children is limited.
Elderly population (aged 65 years and older)
Experience with Sandimmun in elderly patients is limited. Your doctor should monitor your kidney function.
Other medicines and Sandimmun
Inform your doctor or pharmacist if you are taking, have recently taken, or might need to take any other medicines.
In particular, inform your doctor or pharmacist if you are taking any of the following medicines before or during treatment with Sandimmun:
-
Medicines that may affect your potassium levels. These include medicines containing potassium, potassium supplements, potassium-sparing diuretics, and certain medicines used to lower blood pressure.
-
Methotrexate. Used to treat tumors, severe psoriasis, and severe rheumatoid arthritis.
-
Medicines that may increase or decrease ciclosporin (the active substance in Sandimmun) levels in your blood. Your doctor may check your ciclosporin blood levels when starting or stopping other medicines.
-
Medicines that may increase ciclosporin levels in your blood include: antibiotics (such as erythromycin or azithromycin), antifungal agents (voriconazole, itraconazole), medicines used for heart disorders or high blood pressure (diltiazem, nicardipine, verapamil, amiodarone), metoclopramide (used to prevent vomiting), oral contraceptives, danazol (used to treat menstrual disorders), medicines used to treat gout (allopurinol), cholic acid and derivatives (used to treat gallstones), protease inhibitors used to treat HIV, imatinib (used to treat leukemia or tumors), colchicine, telaprevir (used to treat hepatitis C), cannabidiol (used, among others, for treating epileptic seizures).
-
Medicines that may decrease ciclosporin levels in your blood include: barbiturates (used to help you sleep), certain anticonvulsants (such as carbamazepine or phenytoin), octreotide (used to treat acromegaly or neuroendocrine tumors of the intestine), antibacterial medicines used to treat tuberculosis, orlistat (used to help lose weight), herbal medicines containing St. John’s wort, ticlopidine (used after stroke), certain medicines that lower blood pressure (bosentan), and terbinafine (an antifungal medicine used to treat foot and nail infections).
-
Medicines that may affect your kidneys. These include: antibacterial medicines (gentamicin, tobramycin, ciprofloxacin), antifungal medicines containing amphotericin B, medicines used for urinary tract infections containing trimethoprim, cancer medicines containing melphalan, medicines used to reduce stomach acid (H2-receptor antagonists), tacrolimus, painkillers (non-steroidal anti-inflammatory drugs such as diclofenac), fibric acid derivatives (used to reduce blood fat levels).
-
Nifedipine. Used to treat high blood pressure and chest pain. You may experience swollen gums that could grow over your teeth if you are taking nifedipine during ciclosporin treatment.
-
Digoxin (used to treat heart disorders), cholesterol-lowering medicines (HMG-CoA reductase inhibitors, also known as statins), prednisolone, etoposide (used to treat cancer), repaglinide (an oral antidiabetic medicine), immunosuppressants (everolimus, sirolimus), ambrisentan, and specific anticancer medicines called anthracyclines (such as doxorubicin).
-
Sodium mycophenolate or mycophenolate mofetil (an immunosuppressant) and eltrombopag (used to treat bleeding disorders).
If any of these situations apply to you (or you are unsure), inform your doctor or pharmacist before using Sandimmun.
Use of Sandimmun with food and drinks
Do not take Sandimmun with grapefruit or grapefruit juice. This is because it may affect how Sandimmun works.
Pregnancy and breastfeeding
Consult your doctor or pharmacist before using this medicine.
- Inform your doctor if you are pregnant or plan to become pregnant. Experience with Sandimmun in pregnant women is limited. In general, Sandimmun should not be administered during pregnancy. If it is necessary for you to use this medicine, your doctor will discuss the potential benefits and risks of using it during pregnancy.
- Inform your doctor if you are breastfeeding. Breastfeeding is not recommended during treatment with Sandimmun. This is because ciclosporin, the active ingredient, passes into breast milk and could affect your baby.
Hepatitis C
Inform your doctor if you have hepatitis C. Your liver function may change during hepatitis C treatment, which could affect ciclosporin blood levels. Your doctor may need to closely monitor your ciclosporin blood levels and adjust the dose after starting hepatitis C treatment.
Driving and using machines
You may feel drowsy, disoriented, or experience blurred vision after taking Sandimmun. Be cautious when driving or operating machinery while taking Sandimmun until you know how it affects you.
Sandimmun contains castor oil and ethanol
This medicine may cause severe allergic reactions because it contains castor oil.
Sandimmun concentrate for solution for infusion contains 278 mg of alcohol (ethanol) per ml, corresponding to 34.4% v/v. A 100 mg dose of Sandimmun contains 556 mg of ethanol, equivalent to approximately 14 ml of beer or 6 ml of wine. The small amount of alcohol in this medicine will not have any noticeable effect.
3. How to use Sandimmun
Follow exactly the instructions for administering this medicine as given by your doctor. If in doubt, consult your doctor again.
What dose of Sandimmun you will receive
Your doctor will determine the correct dose of Sandimmun for you. This depends on your body weight and the reason for which you are receiving this medicine.
- The usual total daily dose is between 3 and 5 mg per kilogram of body weight. This is divided into two doses.
- Higher doses are usually used before and immediately after your transplant. Lower doses are used once your transplanted organ or bone marrow has stabilized.
- Your doctor will adjust the dose to one that is ideal for you. For this, your doctor may need to perform some blood tests.
How Sandimmun will be used
The medicine will be diluted before use between 1:20 and 1:100 with either saline or 5% glucose solution, using an appropriate aseptic technique, and administered by slow intravenous infusion over 2 to 6 hours. Diluted solutions of the medicine must be discarded 24 hours after preparation.
How long Sandimmun will be used
You will be switched to cyclosporine in capsule or oral solution form (both administered by mouth) as soon as possible.
If you have received more Sandimmun than you should have
Too much of the medicine may affect your kidneys. Blood tests and regular hospital visits will be performed. This will give you the opportunity to discuss your treatment and any problems you may have with your doctor.
If you think you have received too much Sandimmun, inform your doctor immediately.
If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
4. Possible adverse effects
Like all medicines, this medicine can cause adverse effects, although not everyone will experience them.
Some adverse effects may be serious
Tell your doctor immediately if you notice any of the following serious adverse effects:
- Signs of anaphylactoid reactions after intravenous administration of Sandimmun. These reactions may include redness of the face and upper chest, fluid in the lungs, difficulty breathing, wheezing, changes in blood pressure (you may feel faint), and rapid heart rate (tachycardia).
- Like other medicines that affect the immune system, cyclosporine may affect your body's ability to fight certain infections and may cause tumors or other malignant diseases, especially of the skin. Signs of infection may include fever or sore throat.
- Vision disturbances, lack of coordination, clumsiness, memory loss, difficulty speaking or understanding others, and muscle weakness. These may be signs of a brain infection called progressive multifocal leukoencephalopathy.
- Problems in the brain with symptoms such as seizures, confusion, disorientation, reduced sensation, personality changes, agitation, insomnia, vision disturbances, blindness, coma, paralysis of part or all of the body, torticollis, lack of coordination with or without abnormal speech or eye movements.
- Inflammation at the back of the eye that may be associated with blurred vision. It may also affect your vision due to increased pressure inside the head (benign intracranial hypertension).
- Liver injury and dysfunction, with or without yellowing of the eyes or skin, nausea, vision loss, and dark urine.
- Kidney problems, which may greatly reduce the amount of urine you produce.
- Decrease in the number of red blood cells or platelets. These signs include pale skin, fatigue, shortness of breath, dark urine (a sign of red blood cell breakdown), bleeding or bruising without apparent reason, confusion, disorientation, lack of attention, and kidney problems.
Other adverse effects include:
Very common: may affect more than 1 in 10 people
- Kidney problems.
- High blood pressure.
- Headache.
- Uncontrollable body tremors.
- Excessive growth of facial and body hair.
- Increased blood lipids.
If any of these affect you severely, tell your doctor.
Common: may affect up to 1 in 10 people
- Seizures.
- Liver problems.
- Increased blood sugar.
- Fatigue.
- Loss of appetite.
- Nausea (feeling of sickness), vomiting, stomach discomfort/pain, diarrhea.
- Excessive hair growth.
- Acne, hot flushes.
- Fever.
- Decrease in white blood cells.
- Numbness or tingling sensation.
- Muscle pain, muscle spasms.
- Stomach ulcer.
- Excessive growth of gum tissue, which may cover your teeth.
- Increased levels of uric acid or potassium in the blood, decreased magnesium levels in the blood.
If any of these affect you severely, tell your doctor.
Uncommon: may affect up to 1 in 100 people
- Symptoms of brain disturbances including sudden seizures, mental confusion, insomnia, disorientation, vision disturbances, unconsciousness, feeling of weakness in the limbs, impaired movement.
- Skin rash.
- Generalized swelling.
- Weight gain.
- Decrease in red blood cells and platelets in the blood, which may increase the risk of bleeding.
If any of these affect you severely, tell your doctor.
Rare: may affect up to 1 in 1,000 people
- Nerve disturbances with numbness or tingling in the fingers and toes.
- Inflammation of the pancreas with severe upper abdominal pain.
- Muscle weakness, loss of muscle strength, leg or hand or body-wide muscle pain.
- Destruction of red blood cells, including kidney problems with symptoms such as swelling of the face, abdomen, hands and/or feet, reduced urine output, difficulty breathing, chest pain, seizures, unconsciousness.
- Changes in menstrual cycle, breast enlargement in men.
If any of these affect you severely, tell your doctor.
Very rare: may affect up to 1 in 10,000 people
- Inflammation at the back of the eye that may be associated with increased pressure inside the head and deterioration of vision.
If this affects you severely, tell your doctor.
Frequency not known: Cannot be estimated from available data.
- Severe liver problems with or without yellowing of the eyes or skin, nausea (feeling of sickness), loss of appetite, dark urine, swelling of the face, feet, hands and/or whole body.
- Bleeding under the skin or purple spots on the skin, sudden unexplained bleeding.
- Migraine or severe headache, often with dizziness or associated symptoms (nausea, vomiting), and sensitivity to light.
- Pain in the legs and feet.
- Hearing impairment.
If any of these affect you severely, tell your doctor.
If you experience any adverse effects, consult your doctor or pharmacist, even if they are adverse effects not listed in this leaflet.
Additional adverse effects in children and adolescents
No additional adverse effects are expected in children and adolescents compared to adults.
Reporting of adverse effects
If you experience any adverse effect, talk to your doctor or pharmacist, even if it is a possible adverse effect not listed in this leaflet. You can also report them directly via the Spanish Pharmacovigilance System for Human Medicines (www.notificaRAM.es). By reporting adverse effects, you can help provide more information on the safety of this medicine.
5. Storage of Sandimmun
- Keep this medicine out of the sight and reach of children.
- Do not use this medicine after the expiry date stated on the container.
- This medicine does not require special storage temperature conditions.
- After opening the ampoule, the contents should be diluted using proper aseptic technique and administered immediately by a healthcare professional. If not administered immediately, the diluted solution may be stored between 2°C and 8°C (in the refrigerator), provided that the total duration of storage and infusion is less than 24 hours. Any unused diluted solution should be discarded.
Medicines must not be disposed of via wastewater or household waste. Doing so helps protect the environment.
6. Contents of the pack and other information
Composition of Sandimmun
- The active substance is ciclosporin. One ml of concentrate for solution for infusion contains 50 mg of ciclosporin. A 5 ml ampoule contains 250 mg of ciclosporin.
- The other components are: anhydrous ethanol, polyoxyl 40 hydrogenated castor oil.
Appearance of Sandimmun and contents of the pack
Sandimmun concentrate for solution for infusion is supplied in ampoules containing 5 ml of concentrate. The concentrate is a clear, oily, yellowish-brown liquid. It will be used by your doctor or nurse to prepare a solution which will be administered to you via a slow intravenous infusion.
Pack containing 10 ampoules of 5 ml.
Only certain pack sizes may be marketed.
Marketing Authorisation Holder
Novartis Farmacéutica, S.A.
Gran Via de les Corts Catalanes, 764
08013 – Barcelona (Spain)
Telephone: +34 93 306 42 00
Manufacturer
- Novartis (Hellas) S.A.C.I.
12th km National Road Athens-Lamia
14451 Metamorphoses
Greece
- Novartis Farma - Produtos Farmacêuticos S.A.
Avenida Professor Doutor Cavaco Silva, n.º 10E
Taguspark
2740-255 Porto Salvo
Portugal
- Novartis Farma S.p.A.
Via Provinciale Schito 131
80058 Torre Annunziata, NA
Italy
- Novartis Farmaceutica SA
- Gran Via de les Corts Catalanes, 764
- 08013 Barcelona
Spain
- Novartis Hungária Kft.
Bartók Béla út 43-47.
1114 Budapest
Hungary
- Novartis Pharma B.V.
- Haaksbergweg 16
1101 BX Amsterdam
The Netherlands
- Novartis Pharma GmbH
Jakov-Lind-Straße 5, Top 3.05
1020 Wien
Austria
- Novartis Pharma S.A.S.
8-10, rue Henri Sainte-Claire Deville,
92500 Rueil-Malmaison,
France
- Novartis Sverige AB
Torshamnsgatan 48
164 40 Kista
Sweden
- Novartis Farma S.P.A.
Viale Luigi Sturzo, 43
20154-Milano (MI)
Italy
- Novartis Pharma GmbH
Sophie-Germain-Strasse 10
90443 Nürnberg
Germany
This medicinal product is authorised in the European Economic Area (EEA) Member States and in the United Kingdom (Northern Ireland) under the following names:
Netherlands | Sandimmune |
Austria, Belgium, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Slovakia, Slovenia, Spain, Sweden, United Kingdom (Northern Ireland) | Sandimmun |
Date of the most recent review of this leaflet: 03/2025
Other sources of information
Detailed information on this medicine is available on the website of the Spanish Agency of Medicines and Health Products (AEMPS) http://www.aemps.gob.es/